N/A N=20 Perioral Rejuvenation and Upper Lip Enhancement
Perioral Rejuvenation · Upper Lip Projection
Primary: Nasal Tip Projection — 0.601 ratio
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=37 Assessment and Augmentation of Lip Appearance in Specific Study Populations
Lip Aging · Lip Augmentation · Lip
Primary: Change in Lip Vessel's Thickness — 0.833; 0.360 µm
N/A N=273 New Dermal Filler for Lip Augmentation
Lip Augmentation
Primary: Assess Effectiveness of the Treatment Using the Medicis Lip Fullness Scale (MLFS) — 1.8; 1.7; 1.8; 1.8 Change in MLFS score from baseline
Phase 4 N=20 Study of Restylane and Perlane in the Correction of Peri-Oral Wrinkles
Peri-oral Wrinkles
Primary: Local and Systemic Adverse Events — 100 percentage of participants
N/A N=60 Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
Lip Augmentation and Correction of Perioral Rhytids
Primary: Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine — 11 Participants
N/A N=20 Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions
Lip Rejuvenation
Primary: First Impressions — 46.756; 27.769; 46.391; 34.404 score on a scale
N/A N=169 Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Midface Volume Deficit
Primary: Percent Responders With 1 Point Improvement on the Medicis Midface Volume Scale — 67; 8 Participants
Phase 4 N=32 Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
Nasolabial Folds
Primary: Procedural Pain Score — 2.0; 4.1 units on a scale
N/A N=180 Safety/Efficacy Study of Restylane® in Lip Augmentation
Lip Augmentation
Primary: Percentage of Participants With Response — 92.6; 28.9 Percentage of Participants
Phase 4 N=58 Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour
Contour
Primary: Percentage of Participants Who Showed ≥ 1-point Jawline Improvement From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS), as Assessed by the…
N/A N=213 Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation
Lip Augmentation
Primary: Percentage of Subjects With ≥1-Point Improvement on the Investigator Assessed 5-point Lip Fullness Scale 2 (LFS2) — 79.1; 26.1 Percentage of Subjects
N/A N=138 JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines
Patients With Moderate to Severe Perioral Lines
Primary: Percentage of Participants With at Least a 1 Point Improvement From Baseline on the Perioral Lines Severity Scale (POLSS) — 87; 72 percentage of participants
N/A N=62 Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
Nasolabial Fold, Hypoplastic
Primary: NLF-SRS Grade of Nasolabial Folds Change — -1.50 score on a scale
Phase 4 N=60 A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation
Lip Augmentation
Primary: Percentage of Participants With a ≥ 1-point Improvement (Increase) in the Lip Fullness Scale (LFS2) Compared to Baseline Assessment at Day 30 — 93.2 percentage of…
N/A N=281 Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement
Lip Volume Enhancement
Primary: Month 3 Overall Lip Fullness Scale Responder Rate Based on Independent Central Reviewer's Assessment — 34.1; 29.3 Percentage of subjects
N/A N=158 Safety and Effectiveness of PN40082 for Lip Augmentation
Lip Augmentation
Primary: Change in Overall Lip Fullness Grading Scale — 1.52; 1.53 score on a scale
N/A N=225 A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement
Subjects Desiring Lip Augmentation
Primary: Change From Baseline in Evaluating Investigator's Assessment of Lip Fullness on a 5-Point Scale — 1.2; 1.1; 1.1; 1.0 Scores on a Scale
N/A N=110 Saypha® Volume LIdocaine in Nasolabial Folds
Moderate to Severe Nasolabial Folds
Primary: Responder Rate in Reduction of Nasolabial Folds — 34; 39; 73 Participants
N/A N=62 Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement
Lip Enhancement
Primary: Investigator Assessment of the Subject's Overall Lip Fullness on the 4-point Lip Fullness Scale — 93.2 percentage of responders
Phase 4 N=101 Prospective Evaluation of Facial Cosmetic Procedures
Cosmetic Techniques
Primary: Patient Satisfaction With Validated FACE-Q Aesthetics Survey — 28.0; 24.0; 36.0; 36.0 score on a scale
N/A N=80 A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area
Infra-orbital Skin Depressions
Primary: Percentage of Subjects With a ≥1 Grade Improvement From Baseline in Infra-Orbital Area on the Allergan Infra-Orbital Rating Scale (AIRS) on the Right and Left Side — 99…
N/A N=60 Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
Cheek Augmentation · Midface Contour Deficiencies
Primary: Number of Participants With Treatment-Emergent Adverse Events [Safety] — 5 Participants
Phase 4 N=18 Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study
Infraorbital Hollows
Primary: The Primary Objective of This Study is to Determine the Efficacy and Longevity of the Use of Restylane® and Perlane® in Combination for the Rejuvenation of the…
N/A N=148 Restylane Defyne for Correction of Chin Retrusion
Chin Retrusion
Primary: Percentage of Participants (Responders) With At Least 1-Point Improvement From Baseline on the GCRS, as Assessed by the Blinded Evaluator at Month 6 ([Baseline…
N/A N=140 Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition
Jawline Definition
Primary: Percentage of Responders Having At Least a 1-Grade Improvement From Baseline on Both Jawlines Concurrently Based on Galderma Jawline Scale (GJS) at Month 3 as Assessed…
N/A N=60 Pan Facial Volume Restoration
Volume Loss (Soft Tissue Ptosis or Atrophy )
Primary: Mean Change From Baseline in Volume Loss Assessment — -0.8 Score on a scale
N/A N=168 Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Midface Volume Deficit
Primary: Percentage of Responders — 80; 87.2; 76.7 percentage of subjects
N/A N=202 RHA Redensity - Perioral Rhytids
Perioral Rhytids · Aging · Wrinkle
Primary: Change From Baseline in Perioral Rhytids Severity Rating Scale (PR-SRS) Score Rated by the Blinded Live Evaluator (BLE) at Week 8 After Last Treatment. — 121; 4; 29; 47…
N/A N=202 RHA® 3 Versus Restylane-L® for Lip Augmentation
Lip Augmentation · Lip
Primary: Change in TLFS Score (Teoxane Lip Fullness Scale) Between Baseline and Week 12 After Last Treatment of RHA®3 Versus Control Device, as Assessed by the BLE — 1.0; 0.8…
Phase 3 N=84 A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation
Lip Augmentation
Primary: Change From Baseline in Lip Fullness Grading Scale — .82 score on a scale